Rench Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-49,508
| Closed | -$4.08M | – | 52 |
|
|
2023
Q4 | $4.08M | Sell |
49,508
-1,993
| -4% | -$152K | 1.72% | 26 |
|
|
2023
Q3 | $4.04M | Buy |
51,501
+16
| +0% | +$1.34K | 1.85% | 26 |
|
|
2023
Q2 | $4.54M | Buy |
51,485
+1,098
| +2% | +$94.5K | 1.99% | 22 |
|
|
2023
Q1 | $4.06M | Buy |
50,387
+661
| +1% | +$53.9K | 1.94% | 26 |
|
|
2022
Q4 | $3.86M | Sell |
49,726
-582
| -1% | -$47.2K | 1.97% | 24 |
|
|
2022
Q3 | $4.06M | Buy |
50,308
+359
| +0.7% | +$32.3K | 2.28% | 20 |
|
|
2022
Q2 | $4.48M | Buy |
49,949
+1,013
| +2% | +$103K | 2.3% | 19 |
|
|
2022
Q1 | $5.43M | Buy |
48,936
+2,076
| +4% | +$219K | 2.47% | 18 |
|
|
2021
Q4 | $4.85M | Buy |
46,860
+490
| +1% | +$56.7K | 2.19% | 21 |
|
|
2021
Q3 | $5.81M | Sell |
46,370
-165
| -0.4% | -$21.4K | 2.89% | 16 |
|
|
2021
Q2 | $5.78M | Buy |
46,535
+515
| +1% | +$64.7K | 2.88% | 17 |
|
|
2021
Q1 | $5.44M | Buy |
46,020
+1,216
| +3% | +$143K | 2.83% | 16 |
|
|
2020
Q4 | $5.25M | Buy |
44,804
+1,443
| +3% | +$159K | 2.95% | 15 |
|
|
2020
Q3 | $4.51M | Buy |
43,361
+599
| +1% | +$60.2K | 2.87% | 16 |
|
|
2020
Q2 | $3.92M | Sell |
42,762
-224
| -0.5% | -$21.5K | 2.64% | 17 |
|
|
2020
Q1 | $3.88M | Buy |
42,986
+289
| +0.7% | +$30.7K | 3.01% | 16 |
|
|
2019
Q4 | $4.84M | Buy |
42,697
+9,834
| +30% | +$1.08M | 2.79% | 16 |
|
|
2019
Q3 | $3.57M | Buy |
32,863
+596
| +2% | +$62.2K | 2.31% | 20 |
|
|
2019
Q2 | $3.14M | Buy |
32,267
+46
| +0.1% | +$4.2K | 2.01% | 23 |
|
|
2019
Q1 | $2.94M | Buy |
32,221
+74
| +0.2% | +$6.62K | 1.92% | 27 |
|
|
2018
Q4 | $2.92M | Buy |
32,147
+433
| +1% | +$40.5K | 2.14% | 22 |
|
|
2018
Q3 | $3.12M | Sell |
31,714
-487
| -2% | -$45K | 2.08% | 22 |
|
|
2018
Q2 | $2.76M | Sell |
32,201
-822
| -2% | -$68.7K | 1.99% | 23 |
|
|
2018
Q1 | $2.65M | Sell |
33,023
-535
| -2% | -$44.1K | 1.81% | 24 |
|
|
2017
Q4 | $2.71M | Buy |
33,558
+3,433
| +11% | +$275K | 1.76% | 27 |
|
|
2017
Q3 | $2.34M | Buy |
30,125
+3,542
| +13% | +$294K | 1.61% | 32 |
|
|
2017
Q2 | $2.36M | Sell |
26,583
-45
| -0.2% | -$3.79K | 1.74% | 28 |
|
|
2017
Q1 | $2.15M | Buy |
26,628
+141
| +0.5% | +$11K | 1.59% | 30 |
|
|
2016
Q4 | $1.89M | Sell |
26,487
-20
| -0.1% | -$1.57K | 1.49% | 32 |
|
|
2016
Q3 | $2.29M | Sell |
26,507
-25,104
| -49% | -$2.19M | 1.85% | 28 |
|
|
2016
Q2 | $4.48M | Sell |
51,611
-35
| -0.1% | -$2.83K | 3.62% | 11 |
|
|
2016
Q1 | $3.87M | Sell |
51,646
-2,047
| -4% | -$154K | 3.18% | 14 |
|
|
2015
Q4 | $4.13M | Sell |
53,693
-183
| -0.3% | -$13.8K | 3.56% | 12 |
|
|
2015
Q3 | $3.61M | Buy |
53,876
+2,650
| +5% | +$195K | 3.31% | 14 |
|
|
2015
Q2 | $3.8M | Sell |
51,226
-3,181
| -6% | -$243K | 3.31% | 13 |
|
|
2015
Q1 | $4.24M | Sell |
54,407
-3,390
| -6% | -$257K | 3.63% | 10 |
|
|
2014
Q4 | $4.17M | Sell |
57,797
-1,561
| -3% | -$108K | 3.51% | 12 |
|
|
2014
Q3 | $3.68M | Buy |
59,358
+1,510
| +3% | +$96K | 3.14% | 14 |
|
|
2014
Q2 | $3.69M | Buy |
57,848
+112
| +0.2% | +$6.8K | 3.22% | 15 |
|
|
2014
Q1 | $3.55M | Sell |
57,736
-8,038
| -12% | -$468K | 3.37% | 13 |
|
|
2013
Q4 | $3.77M | Buy |
+65,774
| New | +$3.73M | 3.65% | 13 |
|
Other funds holding MDT
Rench Wealth Management's MDT Position: Q1 2024 in Review
Rench Wealth Management sold out of Medtronic (MDT) in Q1 2024, closing a stake of 49,508 shares — an estimated $4.08M sold.
Rench Wealth Management first reported a position in MDT in Q4 2013 and held it in 41 quarters. The position peaked at $5.81M in Q3 2021. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.
- Rench Wealth Management reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
- Rench Wealth Management sold 49,508 Medtronic shares in Q1 2024, an estimated $4.08M.
- Rench Wealth Management first reported a position in Medtronic in Q4 2013 and held it in 41 quarters.
- Rench Wealth Management's Medtronic position peaked at $5.81M in Q3 2021.
- 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.
Based on Rench Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.